These groups included: a high-fat diet group (HF), a high-fat diet with Melanotan-II treatment group (HF + MT-II), a control diet group (C), and a control diet with Melanotan-II treatment group (C + MT-II)
This work was supported by institutional funds from the Feinstein Institutes for Medical Research, and in part through a Northwell Health Cancer Institute Pilot Award for Mentoring in Cancer Research
The decision to combine these agents must be individualized based on patient-specific factors, including medical history, current medications, cardiovascular health, and response to previous weight management interventions
All characterization of this compound is conducted strictly through physicochemical analysis and standardized research methodologies
This reinforced Novos long-running strategy of positioning GLP-1s as disease-modifying cardiometabolic therapies, rather than cosmetic weight-loss drugs